Related Experiment Video

Updated: Nov 29, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.8K

Pediatric Insomnia

Madeline Himelfarb1, Jess P Shatkin1

  • 1Department of Child & Adolescent Psychiatry, New York University, One Park Avenue, 7th Floor, New York, NY 10016, USA.

Child and Adolescent Psychiatric Clinics of North America
|November 23, 2020
PubMed

Insights

Child and adolescent insomnia is common yet often overlooked, impacting crucial brain development. This review guides clinical assessment and treatment, highlighting developmental differences in pediatric insomnia.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Neurology
  • Developmental Psychology

Background:

  • Insomnia is the most prevalent sleep disorder across all age groups.
  • Pediatric insomnia is frequently underdiagnosed and undertreated.
  • Adequate sleep is vital for healthy brain development in children and adolescents.

Purpose of the Study:

  • To provide a comprehensive guide to pediatric insomnia.
  • To detail the clinical assessment and treatment of insomnia in young populations.
  • To describe how insomnia presentation varies with child development stages.

Main Methods:

  • Comprehensive literature review on pediatric insomnia.
  • Analysis of existing clinical guidelines and research.
  • Synthesis of information on developmental variations in insomnia symptoms.

Main Results:

  • Pediatric populations are uniquely vulnerable to insomnia's adverse effects on development.
  • Specific clinical assessment and management strategies are needed for children and adolescents.
  • Insomnia symptoms and impacts manifest differently throughout childhood and adolescence.

Conclusions:

  • Effective clinical assessment and treatment of pediatric insomnia are crucial.
  • Understanding developmental differences is key to managing childhood insomnia.
  • This review serves as a foundational resource for clinicians addressing pediatric sleep disorders.

Keywords:
AdolescentsChildrenCognitive behavior therapy for insomniaInsomniaPediatric insomniaSleepSleep hygiene

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.1K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
406
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
126
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
94
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
270
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
352